Genetic Coronary Risk Factors in Conventionally Low-Risk Patients

Hiroyuki Morita; Hiroki Kurihara; Yasushi Imai; Yoshio Yazaki; Ryozo Nagai

doi:10.1055/s-0037-1613981

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2000; 84(01): 137
DOI: 10.1055/s-0037-1613981

Letters to the Editor

Schattauer GmbH

Genetic Coronary Risk Factors in Conventionally Low-Risk Patients

Hiroyuki Morita

¹From the Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, Japan

,

Hiroki Kurihara

¹From the Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, Japan

,

Yasushi Imai

¹From the Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, Japan

,

Yoshio Yazaki

²The Hospital International Medical Center of Japan, Tokyo, Japan

,

Ryozo Nagai

¹From the Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, Japan

› Author Affiliations

Abstract

Full Text

References

References
1 Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyet P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-4.
2 Morita H, Taguchi J, Kurihara H, Kitaoka M, Kaneda H, Kurihara Y, Maemura K, Shindo T, Minamino T, Ohno M, Yamaoki K, Ogasawara K, Aizawa T, Suzuki S, Yazaki Y. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 1997; 95: 2032-6.
3 Morita H, Kurihara H, Taguchi J, Ohno M, Yazaki Y. ACE and MTHFR gene polymorphisms: Genetic coronary risk factors relating to different aspects of pathophysiology. Thromb Haemost 1998; 80: 200-1.
4 Gallagher PM, Meleady R, Shields DC, Tan KS, McMaster D, Rozen R, Evans A, Graham IM, Whitehead AS. Homocysteine and risk of premature coronary heart disease: Evidence for a common gene mutation. Circulation 1996; 94: 2154-8.
5 Kluijtmans LA, Kastelein JJ, Lindemans J, Boers GH, Heil SG, Bruschke VG, Jukema JW, van den Heuvel LP, Trijbels FJ, Boerma GJ, Verheugt FW, Willems F, Blom HJ. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation 1997; 96: 2573-7.
6 Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, Malinow MR, Willett WC, Rozen R. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 1996; 94: 2410-6.
7 Deloughery TG, Evans A, Sadeghi A, McWilliams J, Henner WD, Taylor Jr LM, Press RD. Common mutation in methylenetetrahydrofolate reductase: Correlation with homocysteine metabolism and late-onset vascular disease. Circulation 1996; 94: 3074-8.